» Articles » PMID: 21804547

Common Variation at 10p12.31 Near MLLT10 Influences Meningioma Risk

Abstract

To identify susceptibility loci for meningioma, we conducted a genome-wide association study of 859 affected individuals (cases) and 704 controls with validation in two independent sample sets totaling 774 cases and 1,764 controls. We identified a new susceptibility locus for meningioma at 10p12.31 (MLLT10, rs11012732, odds ratio = 1.46, P(combined) = 1.88 × 10(-14)). This finding advances our understanding of the genetic basis of meningioma development.

Citing Articles

Genome-wide association study on meningioma risk in Japan: a multicenter prospective study.

Yamada S, Umehara T, Sonehara K, Kijima N, Kawabata S, Takano K J Neurooncol. 2024; 169(2):281-286.

PMID: 39002029 PMC: 11341637. DOI: 10.1007/s11060-024-04727-x.


Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients.

Wang J, Landry A, Raleigh D, Sahm F, Walsh K, Goldbrunner R Neuro Oncol. 2024; 26(10):1742-1780.

PMID: 38695575 PMC: 11449035. DOI: 10.1093/neuonc/noae082.


Polygenic risk scores, radiation treatment exposures and subsequent cancer risk in childhood cancer survivors.

Gibson T, Karyadi D, Hartley S, Arnold M, Berrington de Gonzalez A, Conces M Nat Med. 2024; 30(3):690-698.

PMID: 38454124 PMC: 11029534. DOI: 10.1038/s41591-024-02837-7.


Upregulation of the Long Noncoding RNA CASC10 Promotes Cisplatin Resistance in High-Grade Serous Ovarian Cancer.

Noriega-Rivera R, Rivera-Serrano M, Rabelo-Fernandez R, Perez-Santiago J, Valiyeva F, Vivas-Mejia P Int J Mol Sci. 2022; 23(14).

PMID: 35887085 PMC: 9318856. DOI: 10.3390/ijms23147737.


Pleiotropic variation confers risk of meningioma and estrogen-mediated cancers.

Walsh K, Zhang C, Calvocoressi L, Hansen H, Berchuck A, Schildkraut J Neurooncol Adv. 2022; 4(1):vdac044.

PMID: 35702670 PMC: 9187056. DOI: 10.1093/noajnl/vdac044.


References
1.
Mihaila D, Jankowski M, Gutierrez J, Rosenblum M, Newsham I, Bogler O . Meningiomas: loss of heterozygosity on chromosome 10 and marker-specific correlations with grade, recurrence, and survival. Clin Cancer Res. 2003; 9(12):4443-51. View

2.
Simon M, Bostrom J, Hartmann C . Molecular genetics of meningiomas: from basic research to potential clinical applications. Neurosurgery. 2007; 60(5):787-98. DOI: 10.1227/01.NEU.0000255421.78431.AE. View

3.
Saydam O, Shen Y, Wurdinger T, Senol O, Boke E, James M . Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway. Mol Cell Biol. 2009; 29(21):5923-40. PMC: 2772747. DOI: 10.1128/MCB.00332-09. View

4.
Mawrin C, Perry A . Pathological classification and molecular genetics of meningiomas. J Neurooncol. 2010; 99(3):379-91. DOI: 10.1007/s11060-010-0342-2. View

5.
Cuzick J . A Wilcoxon-type test for trend. Stat Med. 1985; 4(1):87-90. DOI: 10.1002/sim.4780040112. View